Clinical Trial Update: Accuracy of Half of the Usual Radiotracer Dose in SPECT [NA]

View source ↗

Summary

A completed clinical trial evaluating the accuracy of using half the usual radiotracer dose in SPECT imaging for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED